{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:09:19Z","timestamp":1794236959165,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002505"],"award-info":[{"award-number":["82002505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103142"],"award-info":[{"award-number":["82103142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874057"],"award-info":[{"award-number":["81874057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2022371"],"award-info":[{"award-number":["A2022371"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intrahepatic cholangiocarcinoma (ICC) is a malignant disease characterized by onset occult, rapid progression, high relapse rate, and high mortality. However, data on how the tumor microenvironment (TME) regulates ICC metastasis at the transcriptomic level remains unclear. This study aimed to explore the mechanisms and interactions between hepatocytes and ICC cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the interplay between ICC and liver microenvironment through cytokine antibody array analysis. Then we investigated the role of N6-methyladenosine (m<jats:sup>6<\/jats:sup>A) modification and the downstream target in vitro, in vivo experiments, and in clinical specimens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study demonstrated that cytokine CCL3, which is secreted by hepatocytes, promotes tumor metastasis by regulating m<jats:sup>6<\/jats:sup>A modification via vir-like m<jats:sup>6<\/jats:sup>A methyltransferase associated (VIRMA) in ICC cells. Moreover, immunohistochemical analyses showed that VIRMA correlated with poor outcomes in ICC patients. Finally, we confirmed both in vitro and in vivo that CCL3 could activate VIRMA and its critical downstream target SIRT1, which fuels tumor metastasis in ICC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, our results enhanced our understanding of the interaction between hepatocytes and ICC cells, and revealed the molecular mechanism of the CCL3\/VIRMA\/SIRT1 pathway via m<jats:sup>6<\/jats:sup>A-mediated regulation in ICC metastasis. These studies highlight potential targets for the diagnosis, treatment, and prognosis of ICC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03897-y","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:03:08Z","timestamp":1674468188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification"],"prefix":"10.1186","volume":"21","author":[{"given":"Shurui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kege","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoda","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"3897_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168\u201379.","journal-title":"Lancet"},{"key":"3897_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma-evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95\u2013111.","journal-title":"Nat Rev Clin Oncol"},{"key":"3897_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3897_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353\u201363.","journal-title":"J Hepatol"},{"key":"3897_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y. Tumor microenvironment: sanctuary of the devil. Cancer Lett. 2015;368:7\u201313.","journal-title":"Cancer Lett"},{"key":"3897_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.stem.2019.11.014","volume":"26","author":"T Matsumoto","year":"2020","unstructured":"Matsumoto T, Wakefield L, Tarlow BD, Grompe M. In vivo lineage tracing of polyploid hepatocytes reveals extensive proliferation during liver regeneration. Cell Stem Cell. 2020;26:34-47.e3.","journal-title":"Cell Stem Cell"},{"key":"3897_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M de Palma","year":"2017","unstructured":"de Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17:457\u201374.","journal-title":"Nat Rev Cancer"},{"key":"3897_CR8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"3897_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology. 2021;73(Suppl 1):75\u201385.","journal-title":"Hepatology"},{"key":"3897_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2012.06.012","volume":"57","author":"A Gentilini","year":"2012","unstructured":"Gentilini A, et al. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. J Hepatol. 2012;57:813\u201320.","journal-title":"J Hepatol"},{"key":"3897_CR11","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Can Res. 2016;76:4124\u201335.","journal-title":"Can Res"},{"key":"3897_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","volume":"2","author":"MT Chow","year":"2014","unstructured":"Chow MT, Luster AD. Chemokines in cancer. Cancer Immunol Res. 2014;2:1125\u201331.","journal-title":"Cancer Immunol Res"},{"key":"3897_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559\u201372.","journal-title":"Nat Rev Immunol"},{"key":"3897_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cyto.2018.06.018","volume":"118","author":"G Chang","year":"2019","unstructured":"Chang G, Leu JS, Ma L, Xie K, Huang S. Methylation of RNA N6-methyladenosine in modulation of cytokine responses and tumorigenesis. Cytokine. 2019;118:35\u201341.","journal-title":"Cytokine"},{"key":"3897_CR15","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1038\/s41467-021-25710-4","volume":"12","author":"Z Xie","year":"2021","unstructured":"Xie Z, et al. TNF-\u03b1-mediated m6A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. Nat Commun. 2021;12:5373.","journal-title":"Nat Commun"},{"key":"3897_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature25784","volume":"555","author":"A Bertero","year":"2018","unstructured":"Bertero A, et al. The SMAD2\/3 interactome reveals that TGF\u03b2 controls m 6 A mRNA methylation in pluripotency. Nature. 2018;555:256\u20139.","journal-title":"Nature"},{"key":"3897_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41422-018-0037-3","volume":"28","author":"L Lasman","year":"2018","unstructured":"Lasman L, Hanna JH. M6A deposition: A boost from TGF\u03b2. Cell Res. 2018;28:505.","journal-title":"Cell Res"},{"key":"3897_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nsmb.3162","volume":"23","author":"N Liu","year":"2016","unstructured":"Liu N, Pan T. N6-methyladenosine\u2013encoded epitranscriptomics. Nat Struct Mol Biol. 2016;23:98\u2013102.","journal-title":"Nat Struct Mol Biol"},{"key":"3897_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3897_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","volume":"15","author":"KD Meyer","year":"2014","unstructured":"Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15:313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3897_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543:573\u20136.","journal-title":"Nature"},{"key":"3897_CR22","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen J, et al. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69:1028-1038.e6.","journal-title":"Mol Cell"},{"key":"3897_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79-96.e11.","journal-title":"Cancer Cell"},{"key":"3897_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"3897_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"3897_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, et al. METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69:1193\u2013205.","journal-title":"Gut"},{"key":"3897_CR27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"3897_CR28","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2021","unstructured":"Liu T, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2021;48:3816\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3897_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","volume":"38","author":"G Chang","year":"2020","unstructured":"Chang G, et al. YTHDF3 induces the translation of m6A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38:857-871.e7.","journal-title":"Cancer Cell"},{"key":"3897_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen H, et al. RNA N6-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m6A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160:1284-1300.e16.","journal-title":"Gastroenterology"},{"key":"3897_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19:106.","journal-title":"Mol Cancer"},{"key":"3897_CR32","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1038\/s41388-019-0861-z","volume":"38","author":"JY Qian","year":"2019","unstructured":"Qian JY, et al. KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner. Oncogene. 2019;38:6123\u201341.","journal-title":"Oncogene"},{"key":"3897_CR33","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1158\/1078-0432.CCR-16-0460","volume":"22","author":"P Brodt","year":"2016","unstructured":"Brodt P. Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res. 2016;22:5971\u201382.","journal-title":"Clin Cancer Res"},{"key":"3897_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology. 2021;73:75\u201385.","journal-title":"Hepatology"},{"key":"3897_CR35","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/ijms19102885","volume":"19","author":"A Gentilini","year":"2018","unstructured":"Gentilini A, Pastore M, Marra F, Raggi C. The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium. Int J Mol Sci. 2018;19:2885.","journal-title":"Int J Mol Sci"},{"key":"3897_CR36","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.3390\/ijms21207619","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Int J Mol Sci. 2020;21:7619.","journal-title":"Int J Mol Sci"},{"key":"3897_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"13","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m 6 A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;13:319.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3897_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m 6 A RNA methylation. Nat Rev Genet. 2014;15:293\u2013306.","journal-title":"Nat Rev Genet"},{"key":"3897_CR39","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187\u2013200.","journal-title":"Cell"},{"key":"3897_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, et al. RNA N6-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28:507\u201317.","journal-title":"Cell Res"},{"key":"3897_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2021.08.027","volume":"522","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification. Cancer Lett. 2021;522:142\u201354.","journal-title":"Cancer Lett"},{"key":"3897_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13046-021-02072-9","volume":"40","author":"V Miranda-Gon\u00e7alves","year":"2021","unstructured":"Miranda-Gon\u00e7alves V, et al. The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. J Exp Clin Cancer Res. 2021;40:268.","journal-title":"J Exp Clin Cancer Res"},{"key":"3897_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan T, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18:186.","journal-title":"Mol Cancer"},{"key":"3897_CR44","doi-asserted-by":"publisher","first-page":"e20190745","DOI":"10.1084\/jem.20190745","volume":"217","author":"A Dasgupta","year":"2020","unstructured":"Dasgupta A, et al. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020;217:e20190745.","journal-title":"J Exp Med"},{"key":"3897_CR45","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/jnci\/djt118","volume":"105","author":"L Sun","year":"2013","unstructured":"Sun L, et al. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. JNCI J Natl Cancer Inst. 2013;105:887\u201398.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3897_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/neuonc\/noaa180","volume":"23","author":"JJ Miller","year":"2021","unstructured":"Miller JJ, et al. Sirtuin activation targets IDH-mutant tumors. Neuro Oncol. 2021;23:53\u201362.","journal-title":"Neuro Oncol"},{"key":"3897_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2014.08.007","volume":"62","author":"ZY Zhang","year":"2015","unstructured":"Zhang ZY, et al. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma. J Hepatol. 2015;62:121\u201330.","journal-title":"J Hepatol"},{"key":"3897_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.arr.2018.02.004","volume":"43","author":"ALC Ong","year":"2018","unstructured":"Ong ALC, Ramasamy TS. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018;43:64\u201380.","journal-title":"Ageing Res Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03897-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03897-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03897-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T11:06:06Z","timestamp":1674471966000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03897-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03897-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The collection of the clinical sample was approved by the Institutional Review Board of Sun Yat-sen Memorial Hospital, Sun Yat-sen University under the Grant Number: SYSKY-2022-492-01. The in vivo study was approved by the Animal Experimentation Ethics Committee of Sun Yat-sen University Cancer Center, Sun Yat-sen University under Grant Number: L102012020080F. Ethical review and approval were not applicable in bioinformatics and in vitro analysis performed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}